Latest Breaking News On - Avenue therapeutics inc - Page 8 : comparemela.com

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday s Mid-Day Session - Ault Alliance (AMEX:AULT), Avenue Therapeutics (NASDAQ:ATXI)

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

United statesFarfetch limitedQuantumscape corporationRedhill biopharmaCorecard corporationJabil incVerve therapeutics incLeslie incCarvana coAvenue therapeutics incConduit pharmaceuticals incX capital venture acquisition corpRedhill biopharma ltdWellness company incBiodexa pharmaceuticalsYoshiharu global co

Short Interest in Avenue Therapeutics, Inc (NASDAQ:ATXI) Increases By 39 0%

Avenue Therapeutics, Inc. (NASDAQ:ATXI – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 513,700 shares, a growth of 39.0% from the October 15th total of 369,700 shares. Based on an average trading volume of 156,200 shares, […]

United statesGeode capital managementCitadel advisorsAvenue therapeutics company profileVirtu financialSecurities exchange commissionAvenue therapeutics incFortress biotech incAvenue therapeuticsGet free reportTherapeutics trading downFortress biotechExchange commissionDirector lindsaySigma investmentsStreet corp

Avenue Therapeutics Announces Closing of $5 0 Million Public Offering

Avenue Therapeutics Announces Closing of $5 0 Million Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesJaclyn jaffeMaxim groupFortress biotech incMaxim group llc capital marketsAvenue therapeutics incCapital marketsExchange commissionSyndicate departmentTherapeutics announces closingLake street capital marketsAvenue southFortress biotechPrivate securities litigation reform act

Avenue Therapeutics Announces Closing of $5 0 Million Public Offering

Avenue Therapeutics Announces Closing of $5 0 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSyndicate departmentCapital marketsExchange commissionJaclyn jaffeavenue therapeutics incAvenue therapeutics incMaxim group llc capital marketsFortress biotech incMaxim groupLake street capital marketsAvenue southFortress biotechPrivate securities litigation reform actJaffeavenue therapeutics

Avenue Therapeutics Announces Pricing of $5 0 Million Public Offering

Avenue Therapeutics Announces Pricing of $5 0 Million Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJaclyn jaffeMaxim groupMaxim group llc capital marketsAvenue therapeutics incExchange commissionSyndicate departmentCapital marketsFortress biotech incTherapeutics announces pricingLake street capital marketsAvenue southFortress biotechPrivate securities litigation reform act